| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2025 ( Subtotal = $0 ) |
| | 2025 | 2023 | GEL4MED INC | 655 WATERTOWN ST | NEWTONVILLE | MA | 02460-1350 | MIDDLESEX | USA | SB1GM133305 | Antimicrobial dermal matrices to promote infection free wound closure in cutaneous wounds | 000 | 4 | NIH | 4/1/2025 | $0 |
|
| Issue Date FY: 2024 ( Subtotal = $1,529,428 ) |
| | 2024 | 2024 | GEL4MED INC | 655 WATERTOWN ST | NEWTONVILLE | MA | 02460-1350 | MIDDLESEX | USA | R44DK137730 | Antimicrobial dermal matrices to promote infection free wound closure in DTU-DFUs. | 002 | 2 | NIH | 8/29/2024 | $1,529,428 |
| | 2024 | 2023 | GEL4MED INC | 655 WATERTOWN ST | NEWTONVILLE | MA | 02460-1350 | MIDDLESEX | USA | R44DK137730 | Antimicrobial dermal matrices to promote infection free wound closure in DTU-DFUs. | 001 | 1 | NIH | 8/29/2024 | $0 |
| | 2024 | 2023 | GEL4MED INC | 655 WATERTOWN ST | NEWTONVILLE | MA | 02460-1350 | MIDDLESEX | USA | SB1GM133305 | Antimicrobial dermal matrices to promote infection free wound closure in cutaneous wounds | 000 | 4 | NIH | 10/30/2023 | $0 |
| | 2024 | 2023 | GEL4MED INC | 655 WATERTOWN ST | NEWTONVILLE | MA | 02460-1350 | MIDDLESEX | USA | R44DK137730 | Antimicrobial dermal matrices to promote infection free wound closure in DTU-DFUs. | 000 | 1 | NIH | 10/30/2023 | $0 |
| | 2024 | 2021 | GEL4MED INC | 655 WATERTOWN ST | NEWTONVILLE | MA | 02460-1350 | MIDDLESEX | USA | R44GM133305 | Antimicrobial dermal matrices to promote infection free wound closure in cutaneous wounds | 000 | 3 | NIH | 2/25/2024 | $0 |
| | 2024 | 2020 | GEL4MED INC | 655 WATERTOWN ST | NEWTONVILLE | MA | 02460-1350 | MIDDLESEX | USA | R43AI155199 | Antifungal Dermal Templates for Wound Healing | 000 | 1 | NIH | 4/16/2024 | $0 |
| | 2024 | 2020 | GEL4MED INC | 655 WATERTOWN ST | NEWTONVILLE | MA | 02460-1350 | MIDDLESEX | USA | R43EY031615 | Treatment of microbial keratitis and corneal wound healing | 000 | 1 | NIH | 4/9/2024 | $0 |
|
| Issue Date FY: 2023 ( Subtotal = $2,319,996 ) |
| | 2023 | 2023 | GEL4MED INC | 655 WATERTOWN ST | NEWTONVILLE | MA | 02460-1350 | MIDDLESEX | USA | R44DK137730 | Antimicrobial dermal matrices to promote infection free wound closure in DTU-DFUs. | 000 | 1 | NIH | 8/31/2023 | $1,119,996 |
| | 2023 | 2023 | GEL4MED INC | 655 WATERTOWN ST | NEWTONVILLE | MA | 02460-1350 | MIDDLESEX | USA | SB1GM133305 | Antimicrobial dermal matrices to promote infection free wound closure in cutaneous wounds | 000 | 4 | NIH | 9/7/2023 | $1,200,000 |
| | 2023 | 2022 | GEL4MED INC | 655 WATERTOWN ST | NEWTONVILLE | MA | 02460-1350 | MIDDLESEX | USA | R44GM133305 | Antimicrobial dermal matrices to promote infection free wound closure in cutaneous wounds | 003 | 3 | NIH | 9/6/2023 | $0 |
| | 2023 | 2022 | GEL4MED INC | 655 WATERTOWN ST | NEWTONVILLE | MA | 02460-1350 | MIDDLESEX | USA | R44GM133305 | Antimicrobial dermal matrices to promote infection free wound closure in cutaneous wounds | 001 | 3 | NIH | 3/21/2023 | $0 |
| | 2023 | 2021 | GEL4MED INC | 655 WATERTOWN ST | NEWTONVILLE | MA | 02460-1350 | MIDDLESEX | USA | R44GM133305 | Antimicrobial dermal matrices to promote infection free wound closure in cutaneous wounds | 000 | 3 | NIH | 3/21/2023 | $0 |
| | 2023 | 2021 | GEL4MED INC | 655 WATERTOWN ST | NEWTONVILLE | MA | 02460-1350 | MIDDLESEX | USA | R44GM133305 | Antimicrobial dermal matrices to promote infection free wound closure in cutaneous wounds | 002 | 3 | NIH | 9/6/2023 | $0 |
| | 2023 | 2020 | GEL4MED INC | 655 WATERTOWN ST | NEWTONVILLE | MA | 02460-1350 | MIDDLESEX | USA | R43EY031615 | Treatment of microbial keratitis and corneal wound healing | 000 | 1 | NIH | 1/13/2023 | $0 |
| | 2023 | 2019 | GEL4MED INC | 655 WATERTOWN ST | NEWTONVILLE | MA | 02460-1350 | MIDDLESEX | USA | R43AI143079 | Novel dermal templates for prevention and treatment of biofilms in cutaneous wounds | 000 | 1 | NIH | 3/20/2023 | $0 |
|
| Issue Date FY: 2022 ( Subtotal = $50,000 ) |
| | 2022 | 2022 | GEL4MED, INC. | 655 WATERTOWN ST | NEWTONVILLE | MA | 02460-1350 | MIDDLESEX | USA | R44GM133305 | Antimicrobial dermal matrices to promote infection free wound closure in cutaneous wounds | 000 | 3 | NIH | 1/27/2022 | $50,000 |
| | 2022 | 2020 | GEL4MED, INC. | 655 WATERTOWN ST | NEWTONVILLE | MA | 02460-1350 | MIDDLESEX | USA | R43EY031615 | Treatment of microbial keratitis and corneal wound healing | 000 | 1 | NIH | 10/22/2021 | $0 |
| | 2022 | 2020 | GEL4MED, INC. | 655 WATERTOWN ST | NEWTONVILLE | MA | 02460-1350 | MIDDLESEX | USA | R43AI155199 | Antifungal Dermal Templates for Wound Healing | 000 | 1 | NIH | 11/30/2021 | $0 |
| | 2022 | 2020 | GEL4MED, INC. | 655 WATERTOWN ST | NEWTONVILLE | MA | 02460-1350 | MIDDLESEX | USA | R43AI155199 | Antifungal Dermal Templates for Wound Healing | 001 | 1 | NIH | 8/11/2022 | $0 |
| | 2022 | 2017 | GEL4MED INC | 655 WATERTOWN ST | NEWTONVILLE | MA | 02460-1350 | MIDDLESEX | USA | R43DK115347 | Therapeutic cells encapsulation and delivery for improved healing of chronic diabetic wounds | 000 | 1 | NIH | 2/16/2022 | $0 |
| | 2022 | 2017 | GEL4MED INC | 655 WATERTOWN ST | NEWTONVILLE | MA | 02460-1350 | MIDDLESEX | USA | R43GM121127 | Management of bioburden and tissue regeneration in diabetic wounds using engineered matrices | 000 | 1 | NIH | 3/31/2022 | $0 |
|
| Issue Date FY: 2021 ( Subtotal = $1,009,790 ) |
| | 2021 | 2021 | GEL4MED, INC. | 15 WAVERLY ST STE 210 | BRIGHTON | MA | 02135-1243 | SUFFOLK | USA | R44GM133305 | Antimicrobial dermal matrices to promote infection free wound closure in cutaneous wounds | 000 | 3 | NIH | 3/22/2021 | $980,093 |
| | 2021 | 2021 | GEL4MED, INC. | 15 WAVERLY ST STE 210 | BRIGHTON | MA | 02135-1243 | SUFFOLK | USA | R43EY031615 | Treatment of microbial keratitis and corneal wound healing | 001 | 1 | NIH | 1/25/2021 | $29,697 |
| | 2021 | 2020 | GEL4MED, INC. | 15 WAVERLY ST STE 210 | BRIGHTON | MA | 02135-1243 | SUFFOLK | USA | R43EY031615 | Treatment of microbial keratitis and corneal wound healing | 000 | 1 | NIH | 11/17/2020 | $0 |
| | 2021 | 2019 | GEL4MED, INC. | 15 WAVERLY ST STE 210 | BRIGHTON | MA | 02135-1243 | SUFFOLK | USA | R43AI143079 | Novel dermal templates for prevention and treatment of biofilms in cutaneous wounds | 000 | 1 | NIH | 9/21/2021 | $0 |
| | 2021 | 2017 | GEL4MED, INC. | 15 WAVERLY ST STE 210 | BRIGHTON | MA | 02135-1243 | SUFFOLK | USA | R43DK115347 | Therapeutic cells encapsulation and delivery for improved healing of chronic diabetic wounds | 000 | 1 | NIH | 3/3/2021 | $0 |
| | 2021 | 2017 | GEL4MED, INC. | 15 WAVERLY ST STE 210 | BRIGHTON | MA | 02135-1243 | SUFFOLK | USA | R43DK115347 | Therapeutic cells encapsulation and delivery for improved healing of chronic diabetic wounds | 000 | 1 | NIH | 3/3/2021 | $0 |
|
| Issue Date FY: 2020 ( Subtotal = $2,379,931 ) |
| | 2020 | 2020 | GEL4MED, INC. | 15 WAVERLY ST STE 210 | BRIGHTON | MA | 02135-1243 | SUFFOLK | USA | R44GM133305 | Antimicrobial dermal matrices to promote infection free wound closure in cutaneous wounds | 001 | 2 | NIH | 4/27/2020 | $0 |
| | 2020 | 2020 | GEL4MED, INC. | 15 WAVERLY ST STE 210 | BRIGHTON | MA | 02135-1243 | SUFFOLK | USA | R43EY031615 | Treatment of microbial keratitis and corneal wound healing | 000 | 1 | NIH | 6/30/2020 | $380,007 |
| | 2020 | 2020 | GEL4MED, INC. | 15 WAVERLY ST STE 210 | BRIGHTON | MA | 02135-1243 | SUFFOLK | USA | R44GM133305 | Antimicrobial dermal matrices to promote infection free wound closure in cutaneous wounds | 000 | 2 | NIH | 3/26/2020 | $1,699,924 |
| | 2020 | 2020 | GEL4MED, INC. | 15 WAVERLY ST STE 210 | BRIGHTON | MA | 02135-1243 | SUFFOLK | USA | R43AI155199 | Antifungal Dermal Templates for Wound Healing | 000 | 1 | NIH | 8/14/2020 | $300,000 |
| | 2020 | 2019 | GEL4MED, INC. | 15 WAVERLY ST STE 210 | BRIGHTON | MA | 02135-1243 | SUFFOLK | USA | R44GM133305 | Antimicrobial dermal matrices to promote infection free wound closure in cutaneous wounds | 002 | 1 | NIH | 9/5/2020 | $0 |
| | 2020 | 2017 | GEL4MED, INC. | 15 WAVERLY ST STE 210 | BRIGHTON | MA | 02135-1243 | SUFFOLK | USA | R43DK115347 | Therapeutic cells encapsulation and delivery for improved healing of chronic diabetic wounds | 000 | 1 | NIH | 7/15/2020 | $0 |
| | 2020 | 2017 | GEL4MED, INC. | 15 WAVERLY ST STE 210 | BRIGHTON | MA | 02135-1243 | SUFFOLK | USA | R43GM121127 | Management of bioburden and tissue regeneration in diabetic wounds using engineered matrices | 000 | 1 | NIH | 7/27/2020 | $0 |
| | 2020 | 2017 | GEL4MED, INC. | 15 WAVERLY ST STE 210 | BRIGHTON | MA | 02135-1243 | SUFFOLK | USA | R43DK115347 | Therapeutic cells encapsulation and delivery for improved healing of chronic diabetic wounds | 000 | 1 | NIH | 7/15/2020 | $0 |
|
| Issue Date FY: 2019 ( Subtotal = $648,852 ) (Continued on the next page) |
| | 2019 | 2019 | GEL4MED, INC. | 15 WAVERLY ST STE 210 | BRIGHTON | MA | 02135-1243 | SUFFOLK | USA | R43AI143079 | Novel dermal templates for prevention and treatment of biofilms in cutaneous wounds | 000 | 1 | NIH | 3/26/2019 | $300,000 |
| | 2019 | 2019 | GEL4MED, INC. | 15 WAVERLY ST STE 210 | BRIGHTON | MA | 02135-1243 | SUFFOLK | USA | R44GM133305 | Antimicrobial dermal matrices to promote infection free wound closure in cutaneous wounds | 000 | 1 | NIH | 3/28/2019 | $348,852 |
| | 2019 | 2017 | GEL4MED, INC. | 15 WAVERLY ST STE 210 | BRIGHTON | MA | 02135-1243 | SUFFOLK | USA | R43DK115347 | Therapeutic cells encapsulation and delivery for improved healing of chronic diabetic wounds | 000 | 1 | NIH | 10/25/2018 | $0 |
| | 2019 | 2017 | GEL4MED, INC. | 15 WAVERLY ST STE 210 | BRIGHTON | MA | 02135-1243 | SUFFOLK | USA | R43DK115347 | Therapeutic cells encapsulation and delivery for improved healing of chronic diabetic wounds | 001 | 1 | NIH | 8/27/2019 | $0 |
| | 2019 | 2017 | GEL4MED, INC. | 15 WAVERLY ST STE 210 | BRIGHTON | MA | 02135-1243 | SUFFOLK | USA | R43GM121127 | Management of bioburden and tissue regeneration in diabetic wounds using engineered matrices | 000 | 1 | NIH | 7/18/2019 | $0 |
| | 2019 | 2017 | GEL4MED, INC. | 15 WAVERLY ST STE 210 | BRIGHTON | MA | 02135-1243 | SUFFOLK | USA | R43DK115347 | Therapeutic cells encapsulation and delivery for improved healing of chronic diabetic wounds | 001 | 1 | NIH | 8/27/2019 | $0 |
| | 2019 | 2017 | GEL4MED, INC. | 15 WAVERLY ST STE 210 | BRIGHTON | MA | 02135-1243 | SUFFOLK | USA | R43DK115347 | Therapeutic cells encapsulation and delivery for improved healing of chronic diabetic wounds | 000 | 1 | NIH | 10/25/2018 | $0 |
|
